The histone deacetylase inhibitor SAHA acts in synergism with fenretinide and doxorubicin to control growth of rhabdoid tumor cells
暂无分享,去创建一个
M. Kool | M. Meisterernst | H. Jürgens | M. Frühwald | K. Kerl | M. Hasselblatt | M. Jung | Natalia Moreno | M. Eveslage | R. Unland | C. Borchert | David Ries | Dennis Görlich | N. Moreno